B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

TNFRSF10B

MOLECULAR TARGET

TNF receptor superfamily member 10b

UniProt: O14763NCBI Gene: 879516 compounds

TNFRSF10B (TNF receptor superfamily member 10b) is targeted by 16 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting TNFRSF10B

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1clofilium tosylate1.102
2Digoxigenin 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide.1.102
3Tubercidin1.102
4Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
5Methylene Blue0.691
6Methotrexate0.691
7Anisomycin0.691
8Azathioprine0.691
9Calcimycin0.691
10Carbazilquinone0.691
11Dinitrochlorobenzene0.691
12Lanatosides Glycosides from DIGITALIS lanata leaf. Lanatoside C has actions similar to DIGOXIN. Mixtures of lanatosides A, B, and C have also been used. (From Martindale,0.691
13Niclosamide0.691
14Oxyphenbutazone0.691
15Sphingosine0.691
16Strophanthidin 3 beta,5,14-Trihydroxy-19-oxo-5 beta-card-20(22)-enolide.0.691

About TNFRSF10B as a Drug Target

TNFRSF10B (TNF receptor superfamily member 10b) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 16 compounds with documented TNFRSF10B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

TNFRSF10B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.